Somerset, NJ – Nov 01, 2021: WhizAI, the first and only purpose-built augmented consumer platform for the life sciences industry, today announced Richard Clements has joined as Head of Marketing to support its rapid growth and accelerate go to market strategy and execution. As Head of Marketing, Rick will focus on building a comprehensive marketing strategy, driving brand and market awareness through compelling brand stories, and delivering high-quality digital content to clients and prospects that inspires action.
“As we grow our industry footprint, expand our team across the globe and invest in sales and marketing, our clients will benefit from a client first marketing engine,” said Rohit Vashisht, Chief Executive Officer, WhizAI. “We are thrilled to have Rick on our leadership team to innovate our approach to driving sustainable growth while developing robust marketing capabilities and building a world-class marketing function.”
Rick joins WhizAI after nearly two decades in marketing leadership principally at early stage, high growth companies in healthcare and life sciences markets. He has held leadership and marketing roles at SeeBeyond (IPO), Initiate Systems (acquired by IBM), IBM, Novetta, Allscripts and ThoughtSphere. As a marketing leader, he has helped define and execute worldwide marketing, create awareness and demand generation programs, and develop strategies for communicating the business value of complex technologies.
“WhizAI is at the heart of the rapid growth of augmented analytics and the augmented consumer, where the end user is in control and analytics platforms haveto change to adapt to the users,” said Richard Clements, Head of Marketing, WhizAI.“Our contextual AI for life sciences with deep knowledge of who you are, what you are doing, and why you are doing it is vital if we want to place actionable insights directly into the hands of decision makers.”To learn more, please visit www.whiz.ai.
About WhizAI: WhizAI is the first and only purpose-built augmented consumer platform for life sciences, empowering users to get answers to their business questions by simply asking via voice, text on web and mobile. WhizAI is trained on the language and data of life sciences, enabling it to answer even the most complexquestions from billions of records in seconds. Fast, easy, and scalable, WhizAI is the trusted partner of choice at the top global life sciences companies. Asked. Answered. Instantly. Learn more at www.whiz.ai.
People also viewed
Customer Centricity and Digital Experiences which are Redefining Pharma
It is no secret that the pharmaceutical industry has historically flourished from blockbuster products with substantial brand equity, favorable pricing
Awash in Data, Yet Starving for Insights? Transform Life Sciences Commercial Teams with Augmented Analytics
Personalized communication is something the HCPs have come to expect. To do that, pharma sales reps need to know their customers well. In order to know the customer well, they need data. Enterprise pharma companies, however, have many data resources and lots of data at their disposal. In fact, there is a data explosion. So what do you do?
Readiness of Augmented Analytics for Life Sciences Commercial Teams
Demand for smart, agile, and near-instant commercial analytics in Pharma is rising. More contextual, continuous, and connected data and analytics are required to respond to more complex and uncertain business decisions.
Adding Up Data Analytics Total Cost of Ownership (TCO) and How to Lower It
High data analytics expenditures don’t have to be a cost of doing business for life sciences companies. WhizAI lowers total cost of ownership (TCO) while making data insights more accessible to business users. Traditionally, data analytics TCO has been a significant expense for life sciences organizations.
Transforming Life Sciences Commercial Function with AI and Augmented Analytics
In this whitepaper, sponsored by WhizAl, Everest Group explores the business case and profound impact Al and Augmented Analytics can have on the life sciences commercial function across various use cases in Sales, Marketing, and Market Access. They examine what top pharma enterprises are looking for in an augmented analytics tool, a roadmap for how to get started, and a blueprint for adoption.
Augmented Analytics is “On the Rise” on Gartner’s 2022 Hype Cycle for Life Science Commercial Operations
The Gartner® 2022 Hype Cycle™ for Life Science Commercial Operations introduces a new category, Augmented Analytics, this year. WhizAI is listed as a sample vendor in the Augmented Analytics category in this Hype Cycle. This summary report covers the following highlights.
Why Domain Expertise Is Essential for Life Science Analytics
Domain expertise matters. Consider this: Enterprises choose transportation and logistics companies that have created the specific types of services they need. Businesses seek professional services with experience in their industries and look for consultants with good track records in their markets. However, remember that domain expertise benefits extend to analytics platforms, particularly those deployed for life sciences.